Log in to save to my catalogue

Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II rand...

Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II rand...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_717c452c20084f148ec905010a66a23f

Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial

About this item

Full title

Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial

Publisher

London: BioMed Central Ltd

Journal title

Stem cell research & therapy, 2022-06, Vol.13 (1), p.1-264, Article 264

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Type-1 diabetes (T1D) occurs following autoimmune-induced pancreatic beta cells death. Among several treatment modalities, mesenchymal stem cells (MSCs) transplantation is promising for autoimmune disorders due to immunomodulation, regeneration, and migration to damaged tissue upon systemic injection. This study assessed the safety and e...

Alternative Titles

Full title

Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_717c452c20084f148ec905010a66a23f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_717c452c20084f148ec905010a66a23f

Other Identifiers

ISSN

1757-6512

E-ISSN

1757-6512

DOI

10.1186/s13287-022-02941-w

How to access this item